Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 7427
TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM194227(US9200006, 5)
Affinity DataKi:  0.600nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM123098(US8735395, 2 | US9200006, 2 | US10723709, Example ...)
Affinity DataKi:  1.10nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM123097(US8735395, 1 | US9200006, 1 | US10723709, Example ...)
Affinity DataKi:  1.60nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM194228(US9200006, Ref Ex 9)
Affinity DataKi:  2.60nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM194226(US9200006, 4)
Affinity DataKi:  2.70nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM194225(US9200006, 3)
Affinity DataKi:  4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM123098(US8735395, 2 | US9200006, 2 | US10723709, Example ...)
Affinity DataKi: <50nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM194225(US9200006, 3)
Affinity DataKi: <50nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Medivir

US Patent
LigandPNGBDBM123097(US8735395, 1 | US9200006, 1 | US10723709, Example ...)
Affinity DataKi: <50nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM194226(US9200006, 4)
Affinity DataKi:  300nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM194225(US9200006, 3)
Affinity DataKi:  751nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM194227(US9200006, 5)
Affinity DataKi:  1.17E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM194225(US9200006, 3)
Affinity DataKi:  1.40E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM123098(US8735395, 2 | US9200006, 2 | US10723709, Example ...)
Affinity DataKi:  1.70E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM123097(US8735395, 1 | US9200006, 1 | US10723709, Example ...)
Affinity DataKi:  2.00E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM194227(US9200006, 5)
Affinity DataKi:  2.90E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM123097(US8735395, 1 | US9200006, 1 | US10723709, Example ...)
Affinity DataKi:  3.00E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Medivir

US Patent
LigandPNGBDBM123098(US8735395, 2 | US9200006, 2 | US10723709, Example ...)
Affinity DataKi:  3.00E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM194228(US9200006, Ref Ex 9)
Affinity DataKi:  6.10E+3nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM194225(US9200006, 3)
Affinity DataKi: >1.00E+4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM123098(US8735395, 2 | US9200006, 2 | US10723709, Example ...)
Affinity DataKi: >1.00E+4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM123097(US8735395, 1 | US9200006, 1 | US10723709, Example ...)
Affinity DataKi: >1.00E+4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM194226(US9200006, 4)
Affinity DataKi:  1.45E+4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM123098(US8735395, 2 | US9200006, 2 | US10723709, Example ...)
Affinity DataKi:  2.10E+4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM194225(US9200006, 3)
Affinity DataKi:  2.20E+4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin S(Human)
Medivir

US Patent
LigandPNGBDBM123097(US8735395, 1 | US9200006, 1 | US10723709, Example ...)
Affinity DataKi:  2.50E+4nMpH: 7.0Assay Description:Standard assay conditions for the determination of kinetic constants used a fluorogenic peptide substrate, typically H-D-Ala-Leu-Lys-AMC, and were de...More data for this Ligand-Target Pair
In DepthDetails
US Patent